Cybin Inc. (CYBN:NYSEMKT) closed at $8.28 on January 2, 2026, up 1.22% on the day. The stock trades 22.8% below its 52-week high of $10.72 and 72.1% above its 52-week low of $4.81. Cybin Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, CYBN closed higher on 29 days (12%). Its best day was January 12, 2026 (+9.96%) and its worst was November 4, 2025 (-8.32%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 3 times.
Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders, all protected under its ever-growing IP portfolio.
Find more stocks like CYBN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.